Continues PIMCO’S hiring of top industry talent around the world
Firm has already made more than 130 hires globally in 2016, including 14 portfolio managers
NEWPORT BEACH, California (July 6, 2016)
- PIMCO, a leading global investment management firm, has hired Gene Frieda as Executive Vice President and Global Strategist for the firm’s emerging
markets and global strategies and Yacov Arnopolin as Executive Vice President and Emerging Markets Portfolio Manager. They will both be based in PIMCO’s
Mr. Frieda, who will work primarily with the emerging markets team but will also contribute to other global, country and sector strategies, will report to
Andrew Balls, Managing Director and Chief Investment Officer – Global Fixed Income. Mr. Arnopolin, who will focus primarily on emerging markets external
debt strategies, will report to Michael Gomez, Managing Director and Head of the Emerging Markets Portfolio Management team.
“Gene and Yacov are two tremendous additions to our global macroeconomic and emerging markets portfolio management expertise, as their deep experience will
bolster PIMCO’s investment process and tap the investment opportunities we see for clients in emerging markets,” said Dan Ivascyn, Managing Director and
PIMCO’s Group Chief Investment Officer.
He added: “PIMCO will continue to use its considerable resources to hire the best industry talent globally. Already this year, we have hired more than 130
new employees, including 14 portfolio managers and 20 more investment professionals across many areas including alternatives, client analytics, mortgages,
real estate and macroeconomics.”
Mr. Frieda joins PIMCO from Moore Capital Management where he was a Senior Global Strategist. Prior to that, he was the Global Head of Emerging
Markets Research and Strategy at the Royal Bank of Scotland. Prior to joining PIMCO, Mr. Arnopolin was a Managing Director and Portfolio Manager at Goldman
Sachs Asset Management in New York where he helped oversee emerging market portfolios for institutional clients such as pension funds, insurance companies
and sovereign wealth funds.
“Gene and Yacov bring nearly 40 years of combined investment experience and complement other specialized resources we have added in recent years, including
in emerging markets corporates and local markets,” said Mr. Gomez.
“As the adverse global backdrop of lower commodity prices and a stronger dollar give way to a more constructive picture for emerging markets, now is an
exciting time to be adding two such talented investment professionals as Gene and Yacov to the PIMCO team,” said Mr. Balls.
Mr. Frieda joins PIMCO as an Executive Vice President and Global Strategist. Previously, he was a Senior Global Strategist for Moore Capital
Management in London where he was the macro strategist for the firm’s founder and chief investment officer. Prior to that, he ran emerging markets
research and strategy for the Royal Bank of Scotland in London and for 4Cast in London and Singapore. Mr. Frieda holds a Master’s degree in Economics from
the London School of Economics and Bachelor’s degrees in economics and political science from The University of Oklahoma. He serves as a member of the
World Economic Forum’s Committee on the Future of the Global Financial System; the Political Economy of Financial Markets Program at St. Antony’s College,
Oxford; and the United Nation’s Expert Panel on Financing Global Education.
Mr. Arnopolin joins PIMCO as an Executive Vice President and Emerging Markets Portfolio Manager. Prior to joining the firm, he served as Managing Director
overseeing emerging market fixed income portfolios at Goldman Sachs Asset Management. Previously, Yacov worked as portfolio manager at Fortress Investment
Group. Mr. Arnopolin started his career on the sell-side, at Citigroup and Deutsche Bank Fixed Income departments, trading mortgages and emerging markets
products. He has 17 years of financial markets experience, divided between New York and London. Yacov earned a BS in Economics from Carnegie Mellon
University, and serves on the Board of Trustees of the Cancer Research Institute.